Edition:
United States

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

7.80USD
8 Dec 2017
Change (% chg)

$0.29 (+3.86%)
Prev Close
$7.51
Open
$7.78
Day's High
$7.80
Day's Low
$7.39
Volume
5,970
Avg. Vol
12,663
52-wk High
$13.50
52-wk Low
$2.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
FY 2016 Dec '16 0.00 -0.021
Sep '16 0.00 -0.071
Jun '16 0.00 -0.039
Mar '16 0.00 -0.049
FY 2015 Dec '15 0.00 -0.048
Sep '15 0.00 -0.033
Jun '15 0.00 -0.028
Mar '15 0.00 -0.026
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta 2.09 0.83 0.91
Price to Sales (TTM) -- 113.99 5.83
Price to Book (MRQ) 12.06 21.50 5.68
Price to Tangible Book (MRQ) 12.10 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions -- 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.21 5.65
Sales - 5 Yr. Growth Rate -- 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.79 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago -60.47 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate 35.30 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 8.17 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 0.00 16.90 19.24
Interest Coverage (TTM) -345.79 -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -219.17 15.52
Operating Margin (TTM) -- -631.99 6.76
Operating Margin - 5 Yr. Avg. -- -236.03 11.03
Pre-Tax Margin (TTM) -- -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -236.35 11.44
Net Profit Margin (TTM) -- -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -- -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,633,432 858,823,705
Net Income/Employee (TTM) -- -1,703,997 100,224,560
Receivable Turnover (TTM) -- 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) 0.00 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -128.02 -9.13 11.35
Return on Assets - 5 Yr. Avg. -46.89 0.30 12.32
Return on Investment (TTM) -144.94 -11.32 14.47
Return on Investment - 5 Yr. Avg. -72.71 3.50 16.13
Return on Equity (TTM) -182.75 -35.69 16.06
Return on Equity - 5 Yr. Avg. -76.69 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.